Here are the DEF 14A proxy statements from National Health Investors (NHI) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow NHI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full NHI filings page.
National Health Investors, Inc. is asking stockholders to elect seven directors, approve executive pay on an advisory basis, and ratify BDO USA as auditor at its May 27, 2026 hybrid annual meeting. The proxy highlights 2025 results, with Normalized FFO per share up 10.6% to $4.91 and Normalized FAD up 13.7% to $232.1 million, both above initial guidance. Nareit FFO per share rose 2.2% to $4.65, while 2025 TSR increased 15.7%, with three‑ and five‑year TSR of 72.9% and 47.7%. The company completed $392.4 million of investments at an average 8.08% yield and grew SHOP NOI 57.2% to $19.1 million, as net debt to adjusted EBITDA improved to 3.8x. Governance changes include declassifying the board, expanding to nine directors then reducing to seven nominees, raising female representation to 43%, updating key governance documents, and enhancing pay‑for‑performance through capped annual incentives and a more performance‑weighted long‑term equity program.